Lates News
CNS Pharmaceuticals (CNSP.US): The revenue for Q4 2024 financial report was $0, which was the same as the previous period; the earnings per share were -$1.58, compared to -$1020.48 in the previous period, with an expected value of -$6.00.
Latest